[1]
2026. Satisfaction assessment with subcutaneous immunotherapy by ESPIA questionnaire in a pediatric population with allergic phenotype asthma. Revista Alergia México. 73, 2 (jun. 2026), 120–128. DOI:https://doi.org/10.29262/ram.v73i2.1591.